Trivalent influenza vaccine in patients on haemodialysis: Impaired seroresponse with differences for A-H3N2 and A-H1N1 vaccine components
Authors:
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Safety and Immunogenicity of a 45-μg Supplemental Dose of Inactivated Split-Virus Influenza B Vaccine in the ElderlyThe Journal of Infectious Diseases, 1986
- Immunoglobulin G, A and M response to influenza vaccination in different age groups: effects of priming and boostingEpidemiology and Infection, 1986
- Influenza virus antigens conjugated with a synthetic polyelectrolyte: a novel model of vaccinesVaccine, 1985
- Effect of Cancer Chemotherapy on the Immune Response to Influenza Virus Vaccine: Review of Published StudiesClinical Infectious Diseases, 1985
- Simultaneous administration of live, attenuated influenza A vaccines representing different serotypesVaccine, 1985
- A Controlled Trial of Amantadine and Rimantadine in the Prophylaxis of Influenza a InfectionNew England Journal of Medicine, 1982
- Influenza vaccination in renal transplant recipients1978
- ANTIBODY RESPONSE AGAINST CURRENT H1N1 INFLUENZA VIRUS AFTER VACCINATION WITH LAST SEASON'S TRIVALENT VACCINEThe Lancet, 1978
- Response to Influenza Vaccine by Renal Transplant PatientsBMJ, 1974
- EFFECT OF INFLUENZA VACCINES IN STIMULATING ANTIBODY IN VOLUNTEERS WITH PRIOR IMMUNITYThe Lancet, 1973